|
Combination of tissues analysis and immune infiltrate in localized colon cancer using artificial intelligence in PETACC8 study. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Baxalta; Celgene; Lilly; Merck KGaA; MSD; Roche; SERVIER; Sirtex Medical |
Speakers' Bureau - Amgen; Baxalta; Lilly; Merck; MSD; Roche/Genentech; Sanofi; SERVIER |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Advanced Accelerator Applications |
Travel, Accommodations, Expenses - Amgen; Bayer; IPSEN; Novartis |
|
|
No Relationships to Disclose |